Teleflex (NYSE:TFX) Issues FY 2025 Earnings Guidance

Teleflex (NYSE:TFX) updated its FY 2025 earnings guidance on Thursday. The company provided EPS guidance of 13.950-14.350 for the period, compared to the consensus EPS estimate of 15.230. The company issued revenue guidance of $3.0 billion-$3.1 billion, compared to the consensus revenue estimate of $3.2 billion.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on TFX. Royal Bank of Canada cut their price target on Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research note on Friday, November 1st. Mizuho cut their price target on Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research note on Friday, November 1st. Citizens Jmp downgraded Teleflex from an “outperform” rating to a “market perform” rating in a research note on Thursday. Truist Financial cut their target price on Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a research note on Wednesday, December 18th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a report on Monday, December 16th. Four research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $246.00.

Teleflex Price Performance

Shares of TFX stock opened at $138.99 on Friday. The firm has a market cap of $6.46 billion, a P/E ratio of 27.63, a P/E/G ratio of 1.73 and a beta of 1.16. Teleflex has a fifty-two week low of $135.95 and a fifty-two week high of $249.90. The business’s 50 day moving average price is $176.35 and its 200-day moving average price is $205.70. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42.

Teleflex (NYSE:TFX) last released its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, beating the consensus estimate of $3.86 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The company had revenue of $795.40 million for the quarter, compared to analyst estimates of $813.24 million. On average, equities research analysts anticipate that Teleflex will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, March 17th. Investors of record on Friday, March 7th will be given a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 0.98%. Teleflex’s dividend payout ratio is presently 27.04%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.